ELIGO BIOSCIENCE

In News

Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology - PR Newswire

PR Newswire - May 13, 2025

Eligo Bioscience - 2026 Funding Rounds & List of Investors - Tracxn

Tracxn - Jan 27, 2026

Breaking: Eligo Bioscience Reports First-Ever in Vivo Microbiome Base Editing - CRISPR Medicine News

CRISPR Medicine News - Jul 10, 2024

In situ targeted base editing of bacteria in the mouse gut - Nature

Nature - Jul 10, 2024

Gene editing in the microbiome could provide acne solution - Labiotech.eu

Labiotech.eu - Jan 05, 2024

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines - Business Wire

Business Wire - Dec 05, 2023

Eligo Bioscience modifies microbiome that could inactivate antibiotic-resistant genes - Nutrition Insight

Nutrition Insight - Jul 16, 2024

Phages return CRISPR to its microbial roots - Drug Discovery News

Drug Discovery News - Mar 18, 2025

CRISPR Next Frontier: In Vivo Editing of the Microbiome. Interview With Xavier Duportet, Eligo Bioscience - CRISPR Medicine News

CRISPR Medicine News - Feb 03, 2025

Eligo Bioscience: Gene-Editing Company Raises $30 Million - Pulse 2.0

Pulse 2.0 - Dec 14, 2023

Mouse study unlocks genome editing of bacteria in the gut - Phys.org

Phys.org - Jul 11, 2024

Could Crispr Eradicate Acne? - Forbes

Forbes - Jan 11, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment